ask="40.04"
ask_size="1100"
average_daily_volume="1350440"
bid="36.00"
bid_size="600"
book_value="11.83"
change="+3.11"
change_from_200_day_moving_average="-13.67"
change_from_50_day_moving_average="-0.54"
change_from_52_week_high="-40.12"
change_From_52_week_low="8.61"
change_in_percent="+8.43%"
close="39.99"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.82"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="40.11"
high_52_weeks="80.11"
last_trade_date="1/31/2017"
last_trade_price="39.99"
last_trade_size="100"
last_trade_time="4:00pm"
low="35.98"
low_52_weeks="31.38"
market_capitalization="3.43B"
moving_average_200_day="53.66"
moving_average_50_day="40.53"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.57"
open="36.48"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="-25.48%"
percent_change_from_50_day_moving_average="-1.33%"
percent_change_from_52_week_high="-50.08%"
percent_change_from_52_week_low="+27.44%"
previous_close="36.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.12"
price_per_sales="84.95"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="1023147"
weeks_range_52="31.38 - 80.11"
